CORRECTION article

Front. Immunol.

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1661243

Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid

Provisionally accepted
Na  ZhangNa Zhang1Ming  WangMing Wang2Lili  HouLili Hou1Yanyu  ZhangYanyu Zhang1Yan  ZhaoYan Zhao1Luyang  DuLuyang Du2Li  XiaoqingLi Xiaoqing1Xia  LiuXia Liu1Hongwei  ZhouHongwei Zhou1Jiaxuan  HaoJiaxuan Hao1Jing  TianJing Tian1Qiuping  YuQiuping Yu2Lixia  LiLixia Li2Fangming  ChengFangming Cheng2Hai-Zhou  ZhouHai-Zhou Zhou1*
  • 1First Affiliated Hospital of Harbin Medical University, Harbin, China
  • 2Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China

The final, formatted version of the article will be published soon.

Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid Na Zhang 1†, Ming Wang2†, Lili Hou1†, Yanyu Zhang1, Yan Zhao1, Luyang Du2, Xiaoqing Li1, Xia Liu1, Hongwei Zhou1, Jiaxuan Hao1, Jing Tian4, Qiuping Yu2, Lixia Li2, Fangming Cheng4, Hai-Zhou Zhou 1* 1Department of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China, 2Global Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China, 3Dermatology, The First Affiliated Hospital of Harbin Medical University, Harbin, China, 4Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China †These three authors contributed equally to this work *Correspondence: Hai-ZhouZhou, MD, PhD E-mail: haizhouzhou@163.com Keywords: Pemphigus1, Bullous Pemphigoid2, Desmoglein3, BP1804, BP2305, Chemiluminescen Correction on: 1.Author affiliation: The affiliation for Ming Wang was erroneously given as: Department of Pathology, University of Cambridge, Cambridge, United Kingdom The correct affiliation is: Global Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China, 2.Conflict of interest statement The conflict of interest statement was erroneously given as Authors LD, QY, LL and FC were employed by Shenzhen YHLO Biotech Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The correct conflict of interest statement is Authors MW, LD, QY, LL and FC were employed by Shenzhen YHLO Biotech Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.

Keywords: Pemphigus, Bullous pemphigoid, desmoglein, BP180, BP230, Chemiluminescent immunoassay

Received: 07 Jul 2025; Accepted: 09 Jul 2025.

Copyright: © 2025 Zhang, Wang, Hou, Zhang, Zhao, Du, Xiaoqing, Liu, Zhou, Hao, Tian, Yu, Li, Cheng and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hai-Zhou Zhou, First Affiliated Hospital of Harbin Medical University, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.